Lates News

APGE US stocks surged nearly 30% before trading, and the drug APG777, which targets atopic dermatitis, has achieved positive results in trials; KALV soared over 15% as the company's oral drug EKTERLY for acute HAE attacks was approved by the FDA; Wolfspeed continued to rise by over 20%, following a sharp increase of nearly 53% in the previous trading day.